News Chart NFL Biosciences

Stocks

Real-time Euronext Paris 11:55:00 2026-09-09 EDT			5-day change	1st Jan Change
0.8840 ^EUR	-0.11%		+4.00%	-24.96%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

411efffc476ec.7DThI9O5vrHNjiqBrgRyNOgtya_xtjhwtpOb1olSPfk.rXimTOLp-_b5-HrK5F4Te55sgcaU-VQi7-b-jL4NcKmVZtRbmMHS6__4XQ~37763d10726e9fa8b12839ba64f30d4d